6-bromo-1-methyl-1H-indole-3-carbonitrile | 1361092-69-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 6-bromo-1-methyl-1H-indole-3-carbonitrile
• 英文别名: 6-Bromo-1-methyl-1H-indole-3-carbonitrile；6-bromo-1-methylindole-3-carbonitrile
• CAS: 1361092-69-4
• 化学式: C₁₀H₇BrN₂
• 分子量: 235.083
• InChiKey: SOTVYPLSYGORIA-UHFFFAOYSA-N

物化性质

• 沸点：
  383.1±22.0 °C(Predicted)
• 密度：
  1.50±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  28.7
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  6-溴吲哚-3-甲醛 在 甲酸 、 盐酸羟胺 、 sodium formate 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 6-bromo-1-methyl-1H-indole-3-carbonitrile
  参考文献：
  名称：

  Synthesis of Novel Indolyl-1,2,4-triazoles as Potent and Selective Anticancer Agents

  摘要：

  A diverse series of 22 indolyl-1,2,4-triazole congeners (6 and 7) have been synthesized from the reaction of indole-3-carbonitrile (4) or (5) with appropriate acid hydrazides in the presence of potassium carbonate. Synthesized compounds were evaluated for their cytotoxicity against six human cancer cell lines, and some of the compounds displayed promising activity. In particular, 3-(3',4',5'-trimethoxyphenyl)-5-(N-methyl-3'-indolyl)-1,2,4-triazole (7i) and 3-(4'-piperidinyl)-5-(N-methyl-3'-indolyl)-1,2,4-triazole (7n) were the most promising and broadly active compounds against the tested cell lines. It was interesting to note that the trimethoxyphenyl analog 7i showed twofold selective cytotoxicity against PaCa2 cell line (IC50 0.8 mu m), whereas piperidinyl analog 7n was found to be selectively cytotoxic against MCF7 cell line (IC50 1.6 mu m). Notably, the 4-fluorophenyl derivative 7c exhibited selective cytotoxicity against PC3 cell line (IC50 4 mu m). The structure-activity relationship study revealed that substituents including 3,4,5-trimethoxyphenyl, 3,4-dimethoxyphenyl, 4-benzyloxy-3-methoxyphenyl, 4-piperidinyl, 4-fluorophenyl and N-methylindole are beneficial for the activity of indolyl-1,2,4-triazoles (6 and 7).

  DOI：

  10.1111/j.1747-0285.2010.01051.x

文献信息

• [EN] HYDROXY CONTAINING FXR (NR1H4) MODULATING COMPOUNDS<br/>[FR] COMPOSÉS MODULATEURS DE FXR (NR1H4) CONTENANT DES GROUHYDROXY
  申请人：GILEAD SCIENCES INC

  公开号：WO2016096115A1

  公开（公告）日：2016-06-23

  The present invention relates to compounds (1) which bind to the NR1 H4 receptor (FXR) and act as agonists of FXR. The invention further relates to the use of the compounds (1) for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and to a process for the synthesis of said compounds.

  本发明涉及结合NR1 H4受体（FXR）并作为FXR激动剂的化合物（1）。本发明还涉及利用这些化合物（1）制备药物以治疗疾病和/或病况，通过这些化合物结合所述核受体，并涉及这些化合物的合成过程。
• Copper-mediated C3-cyanation of indoles by the combination of amine and ammonium
  作者：Bin Liu、Jiehui Wang、Bo Zhang、Yang Sun、Lei Wang、Jianbin Chen、Jiang Cheng

  DOI：10.1039/c3cc49339c

  日期：——

  A copper-promoted C3-cyanation of both the free N–H and N-protected indoles by N,N,N′,N′-tetramethyl-ethane-1,2-diamine (TMEDA) and ammonium is achieved. The iminium ion acts as the intermediate in this transformation, which is sequentially electrophilically attacked by indole and H2O followed by hydrolyzation to form the aldehyde. Then the reaction between the aldehyde and ammonium afforded nitriles. The reaction employs O2 as a clean oxidant with good efficiency and functional group tolerance. Thus, it represents a facile and safe procedure leading to 3-cyano indoles.

  通过 N,N,N′,N′-四甲基乙烷-1,2-二胺（TMEDA）和铵的促进，铜催化的 C3-氰化反应成功实现了游离 N–H 和 N-保护吲哚的氰化。亚胺离子作为该转化过程中的中间体，依次受到吲哚和 H2O 的亲电攻击，然后水解形成醛。接着，醛与铵的反应生成腈。这一反应采用 O2 作为清洁氧化剂，具有良好的效率和官能团耐受性。因此，它代表了一种简便且安全的步骤，能够产生 3-氰吲哚。
• HYDROXY CONTAINING FXR (NR1H4) MODULATING COMPOUNDS
  申请人：Gilead Sciences, Inc.

  公开号：US20160176861A1

  公开（公告）日：2016-06-23

  The present invention relates to compounds which bind to the NR1H4 receptor (FXR) and act as agonists of FXR. The invention further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of said nuclear receptor by said compounds and to a process for the synthesis of said compounds.

  本发明涉及与NR1H4受体（FXR）结合并作为FXR激动剂的化合物。本发明进一步涉及利用这些化合物制备药物，通过这些化合物与该核受体结合治疗疾病和/或病况，以及制备这些化合物的合成过程。
• Electrosynthesis of (hetero)aryl nitriles from α-imino-oxy acids <i>via</i> oxidative decarboxylation/N–O cleavage
  作者：Hui-Shan Lin、Shu-Jun Chen、Jing-Mei Huang

  DOI：10.1039/d2cc02986c

  日期：——

  A new method for the synthesis of (hetero)aryl nitriles via iminyl radicals has been developed through the electrochemical oxidative decarboxylation of α-imino-oxy acids. This protocol provides an efficient approach to nitriles with a broad range of functional-group tolerance under ambient conditions and can be applied for one-pot gram-scale synthesis.

  通过 α-亚氨基-含氧酸的电化学氧化脱羧，开发了一种通过亚氨基自由基合成（杂）芳基腈的新方法。该协议为在环境条件下具有广泛的官能团耐受性的腈提供了一种有效的方法，可用于一锅克级合成。
• US9751874B2
  申请人：——

  公开号：US9751874B2

  公开（公告）日：2017-09-05